Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.68 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.66 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | BRD4 | O60885 | 1/20 | 0.61 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | MB | P02144 | 1/20 | 0.61 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acedoben SCHEMBL1458995 | 0.98 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1CACNA1BAPBA1SMN1; SMN2 | |
| Acedoben SCHEMBL11793874 | 0.98 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1CACNA1BAPBA1SMN1; SMN2 | |
| Acedoben SCHEMBL3464430 | 0.98 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1CACNA1BAPBA1SMN1; SMN2 | |
| Acedoben SCHEMBL11274912 | 0.98 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1CACNA1BAPBA1SMN1; SMN2 | |
| Acedoben SCHEMBL11257704 | 0.96 | ALDH1A1 (0.63) | ALDH1A1L3MBTL1CACNA1BAPBA1SMN1; SMN2 | |
| SCHEMBL3644520 | 0.94 | L3MBTL1 (0.76) | ALDH1A1L3MBTL1CACNA1BAPBA1SMN1; SMN2 | |
| SCHEMBL5450291 | 0.94 | MAPT (0.71) | ALDH1A1L3MBTL1CACNA1BAPBA1SMN1; SMN2 | |
| SCHEMBL22461604 | 0.92 | CACNA1B (0.79) | ALDH1A1L3MBTL1CACNA1BAPBA1SMN1; SMN2 | |
| SCHEMBL22461605 | 0.92 | CACNA1B (0.79) | ALDH1A1L3MBTL1CACNA1BAPBA1SMN1; SMN2 | |
| Acedoben SCHEMBL9724003 | 0.92 | MAPT (0.77) | ALDH1A1L3MBTL1CACNA1BAPBA1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16250 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026103747-A1 | SALT OF THIAZOLE DERIVATIVE INHIBITOR, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏豪森药业集团有限公司 | 2026-05-21 | — | — | WO | claimed |
| CN-122036704-A | Free base crystal form or acid salt of biaryl compound, preparation method and medical application thereof | 江苏豪森药业集团有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-12624050-B2 | Three fused ring derivative-containing salt or crystal form and pharmaceutical composition thereof | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2026-05-12 | — | — | US | claimed |
| CN-106119113-B | Organisms for the production of 1, 3-butanediol | 基因组股份公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4721739-A1 | CSF-1R INHIBITOR PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | Abbisko Therapeutics Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| US-12588698-B2 | Aerosolizable nicotine-containing formulations | Ventus Medical Limited (GB) | 2026-03-31 | — | — | US | claimed |
| US-12590065-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS, INC. (US) | 2026-03-31 | — | — | US | claimed |
| WO-2026044024-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF | I2O THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250375461-A1 | IDENTIFICATION OF A NEW POTENT INHIBITOR OF MYCOBACTERIAL GROWTH | UNIV BROWN (US) | 2025-12-11 | — | — | US | claimed |
| US-4221794-A | Method of imparting immunomodulating and antiviral activity | NEWPORT PHARMACEUTICALS INTERNATIONAL, INC. (US) | 1980-09-09 | — | — | US | claimed |
| US-4221909-A | P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1980-09-09 | — | — | US | claimed |
| US-RE30379-E | ANTIVIRAL ACTIVITY | STRATEGIC MEDICAL RESEARCH CORP. (US) | 1980-08-19 | — | — | US | claimed |
| US-RE30354-E | VIRICIDES | STRATEGIC MEDICAL RESEARCH CORP. (US) | 1980-07-29 | — | — | US | claimed |
| EP-0009154-A1 | Complexes of 9-hydroxyalkyl-purines, processes for preparing them and therapeutical compositions containing the complexes as active ingredients | Newport Pharmaceuticals International, Inc. (US) | 1980-04-02 | — | — | EP | claimed |
| US-4017608-A | VIRICIDES | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1977-04-12 | — | — | US | claimed |
| US-4016261-A | VIRICIDE MONOSACCHARIDES | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1977-04-05 | — | — | US | claimed |
| US-3965262-A | OR MEMORY IN WARM BLOODED ANIMALSMONOSACCHARIDE DERIVATIVES | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1976-06-22 | — | — | US | claimed |
| US-3939146-A | VIRICIDE | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1976-02-17 | — | — | US | claimed |
| US-3939145-A | VIRICIDE | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1976-02-17 | — | — | US | claimed |